Peripheral Vascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Peripheral Vascular Disease stocks.

Peripheral Vascular Disease Stocks Recent News

Date Stock Title
Jul 3 MMSI Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
Jul 3 BSX Artisan Global Discovery Fund Trimmed Boston Scientific Corporation (BSX) for Valuation Discipline
Jul 2 BSX Medtronic Loses 5% in a Month: What's Next for MDT Investors?
Jul 2 BSX There Are Better Options Than Boston Scientific
Jul 2 MMSI Merit Medical pays Endogastric $105M for acid reflux treatment
Jul 2 MMSI Merit Medical to acquire EndoGastric Solutions for $105m
Jul 1 ITGR Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028 and Upsize of Revolving Credit Facility
Jul 1 MMSI Merit Medical signs asset purchase agreement with EndoGastric Solutions
Jul 1 LMAT Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
Jul 1 MMSI Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
Jul 1 MMSI Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Jul 1 BSX Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results
Jun 30 LMAT LeMaitre: Further Upsides Supported By Longer Competitive Advantage Period
Jun 29 ITGR Integer Holdings (NYSE:ITGR) Has Some Way To Go To Become A Multi-Bagger
Jun 28 BSX Boston Scientific (BSX) Ascends While Market Falls: Some Facts to Note
Jun 28 ITGR Why Integer (ITGR) is a Top Value Stock for the Long-Term
Jun 27 ITGR Integer Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024
Jun 27 LNTH Lantheus acquires global rights to Life Molecular's drug for prostate and breast cancers
Jun 27 LNTH Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
Peripheral Vascular Disease

Peripheral artery disease (PAD) is an abnormal narrowing of arteries other than those that supply the heart or brain. When narrowing occurs in the heart, it is called coronary artery disease, and in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms include skin ulcers, bluish skin, cold skin, or abnormal nail and hair growth in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke. Up to 50% of people with PAD do not have symptoms.The greatest risk factor for PAD is cigarette smoking. Other risk factors include diabetes, high blood pressure, kidney problems, and high blood cholesterol. The most common underlying mechanism of peripheral artery disease is atherosclerosis, especially in individuals over 40 years old. Other mechanisms include artery spasm, blood clots, trauma, fibromuscular dysplasia, and vasculitis. PAD is typically diagnosed by finding an ankle-brachial index (ABI) less than 0.90, which is the systolic blood pressure at the ankle divided by the systolic blood pressure of the arm. Duplex ultrasonography and angiography may also be used. Angiography is more accurate and allows for treatment at the same time; however, it is associated with greater risks.It is unclear if screening for peripheral artery disease in people without symptoms is useful as it has not been properly studied. In those with intermittent claudication from PAD, stopping smoking and supervised exercise therapy improve outcomes. Medications, including statins, ACE inhibitors, and cilostazol may also help. Aspirin does not appear to help those with mild disease but is usually recommended in those with more significant disease due to the increased risk of heart attacks. Anticoagulants such as warfarin are not typically of benefit. Procedures used to treat the disease include bypass grafting, angioplasty, and atherectomy.In 2015, about 155 million people had PAD worldwide. It becomes more common with age. In the developed world, it affects about 5.3% of 45- to 50-year-olds and 18.6% of 85- to 90-year-olds. In the developing world, it affects 4.6% of people between the ages of 45 and 50 and 15% of people between the ages of 85 and 90. PAD in the developed world is equally common among men and women, though in the developing world, women are more commonly affected. In 2015 PAD resulted in about 52,500 deaths, which is an increase from the 16,000 deaths in 1990.

Browse All Tags